Stevanato Group S.p.A. (NYSE: STVN) stock fell -0.94% on Friday to $29.37 against a previous-day closing price of $29.65. With 1.05 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.31 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $29.61 whereas the lowest price it dropped to was $28.78. The 52-week range on STVN shows that it touched its highest point at $36.30 and its lowest point at $13.71 during that stretch. It currently has a 1-year price target of $34.05. With its current market cap of 8.76 billion, STVN has annualized dividend of $0.06 while the current yield stands at 0.20%. Beta for the stock currently stands at 0.82.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of STVN was down-trending over the past week, with a drop of -2.88%, but this was down by -8.16% over a month. Three-month performance dropped to -4.70% while six-month performance rose 23.66%. The stock gained 63.26% in the past year, while it has gained 63.44% so far this year. A look at the trailing 12-month EPS for STVN yields 0.59 with Next year EPS estimates of 0.69. For the next quarter, that number is 0.15. This implies an EPS growth rate of 1.50% for this year and 14.57% for next year.
Float and Shares Shorts:
At present, 264.70 million STVN shares are outstanding with a float of 64.82 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.83 million, which was 0.31% higher than short shares on Jul 30, 2023. In addition to Mr. Franco Stevanato as the firm’s Exec. Chairman, Mr. Franco Moro serves as its CEO, COO & Director.
Through their ownership of 11.49% of STVN’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, STVN reported revenue of $234.25M and operating income of $43.84M. The EBITDA in the recently reported quarter was $59.88M and diluted EPS was $0.12.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for STVN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With STVN analysts setting a high price target of $34.17 and a low target of $26.34, the average target price over the next 12 months is $31.40. Based on these targets, STVN could surge 16.34% to reach the target high and fall by -10.32% to reach the target low. Reaching the average price target will result in a growth of 6.91% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.